Cargando…
The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda
BACKGROUND: The Oral Polio Vaccine (OPV or Sabin) is genetically unstable and may mutate to form vaccine-derived polioviruses (VDPVs). METHODS: In 2014, two VDPVs type 2 were identified during routine surveillance of acute flaccid paralysis (AFP) cases. Consequently, a retrospective VDPV survey was...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922010/ https://www.ncbi.nlm.nih.gov/pubmed/29699577 http://dx.doi.org/10.1186/s12985-018-0990-y |
_version_ | 1783318127137783808 |
---|---|
author | Nanteza, Mary Bridget Bakamutumaho, Barnabas Kisakye, Annet Namuwulya, Prossy Bukenya, Henry Katushabe, Edson Bwogi, Josephine Byabamazima, Charles Rutebarika Williams, Raffaella Gumede, Nicksy |
author_facet | Nanteza, Mary Bridget Bakamutumaho, Barnabas Kisakye, Annet Namuwulya, Prossy Bukenya, Henry Katushabe, Edson Bwogi, Josephine Byabamazima, Charles Rutebarika Williams, Raffaella Gumede, Nicksy |
author_sort | Nanteza, Mary Bridget |
collection | PubMed |
description | BACKGROUND: The Oral Polio Vaccine (OPV or Sabin) is genetically unstable and may mutate to form vaccine-derived polioviruses (VDPVs). METHODS: In 2014, two VDPVs type 2 were identified during routine surveillance of acute flaccid paralysis (AFP) cases. Consequently, a retrospective VDPV survey was conducted to ensure that there was no circulating VDPV in the country. All Sabin poliovirus isolates identified in Uganda 6 months before and 6 months after were re-screened; Sabin 1 and 3 polioviruses were re-screened for Sabin 2 and Sabin 2 polioviruses were re-screened for VDPVs type 2. The Poliovirus rRT-PCR ITD/VDPV 4.0 assay and sequencing were used respectively. RESULTS: The first two VDPVs type2 were identified in Eastern Uganda and the third was identified during the survey from South-western Uganda. These regions had low OPV coverage and poor AFP surveillance indicators. CONCLUSION: The retrospective VDPV survey was a useful strategy to screen for VDPVs more exhaustively. Supplementary surveillance methods need to be encouraged. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12985-018-0990-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5922010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59220102018-05-07 The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda Nanteza, Mary Bridget Bakamutumaho, Barnabas Kisakye, Annet Namuwulya, Prossy Bukenya, Henry Katushabe, Edson Bwogi, Josephine Byabamazima, Charles Rutebarika Williams, Raffaella Gumede, Nicksy Virol J Research BACKGROUND: The Oral Polio Vaccine (OPV or Sabin) is genetically unstable and may mutate to form vaccine-derived polioviruses (VDPVs). METHODS: In 2014, two VDPVs type 2 were identified during routine surveillance of acute flaccid paralysis (AFP) cases. Consequently, a retrospective VDPV survey was conducted to ensure that there was no circulating VDPV in the country. All Sabin poliovirus isolates identified in Uganda 6 months before and 6 months after were re-screened; Sabin 1 and 3 polioviruses were re-screened for Sabin 2 and Sabin 2 polioviruses were re-screened for VDPVs type 2. The Poliovirus rRT-PCR ITD/VDPV 4.0 assay and sequencing were used respectively. RESULTS: The first two VDPVs type2 were identified in Eastern Uganda and the third was identified during the survey from South-western Uganda. These regions had low OPV coverage and poor AFP surveillance indicators. CONCLUSION: The retrospective VDPV survey was a useful strategy to screen for VDPVs more exhaustively. Supplementary surveillance methods need to be encouraged. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12985-018-0990-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-27 /pmc/articles/PMC5922010/ /pubmed/29699577 http://dx.doi.org/10.1186/s12985-018-0990-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Nanteza, Mary Bridget Bakamutumaho, Barnabas Kisakye, Annet Namuwulya, Prossy Bukenya, Henry Katushabe, Edson Bwogi, Josephine Byabamazima, Charles Rutebarika Williams, Raffaella Gumede, Nicksy The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda |
title | The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda |
title_full | The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda |
title_fullStr | The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda |
title_full_unstemmed | The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda |
title_short | The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda |
title_sort | detection of 3 ambiguous type 2 vaccine-derived polioviruses (vdpv2s) in uganda |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922010/ https://www.ncbi.nlm.nih.gov/pubmed/29699577 http://dx.doi.org/10.1186/s12985-018-0990-y |
work_keys_str_mv | AT nantezamarybridget thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT bakamutumahobarnabas thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT kisakyeannet thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT namuwulyaprossy thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT bukenyahenry thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT katushabeedson thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT bwogijosephine thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT byabamazimacharlesrutebarika thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT williamsraffaella thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT gumedenicksy thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT nantezamarybridget detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT bakamutumahobarnabas detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT kisakyeannet detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT namuwulyaprossy detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT bukenyahenry detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT katushabeedson detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT bwogijosephine detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT byabamazimacharlesrutebarika detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT williamsraffaella detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda AT gumedenicksy detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda |